# Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients

> **NCT02024074** · PHASE1 · TERMINATED · sponsor: **Emory University** · enrollment: 1 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Sestamibi (Tc-MBI) scan of the breast

## Key facts

- **NCT ID:** NCT02024074
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study terminated by the Sponsor due to slow enrollment
- **Last updated:** 2015-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024074, "Evaluation of Magnetic Resonance Imaging (MRI) vs Molecular Breast Imaging (Tc-MBI) in Breast Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02024074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*